Haleon Health Products

Haleon is a world-leading consumer healthcare company headquartered in the United Kingdom. It was established in July 2022 as a result of the demerger of GSK's (GlaxoSmithKline) consumer healthcare business. The company manages a vast portfolio of globally recognized brands including Sensodyne, Voltaren, Panadol, Advil, and Centrum. Manufacturing operations are spread globally across several continents, with major facilities located in the UK, USA, Europe, and Asia to support local and international demand. As a standalone entity, Haleon focuses exclusively on consumer health, combining deep scientific expertise with consumer insights to provide everyday health solutions. The company is listed on both the London Stock Exchange and the New York Stock Exchange, representing a significant shift in the global healthcare and personal care landscape.